Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples